Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract

F G de Miranda, J C Vilar, I A Alves, S C Cavalcanti, A R Antoniolli, F G de Miranda, J C Vilar, I A Alves, S C Cavalcanti, A R Antoniolli

Abstract

Background: Tabebuia avellanedae is a tree from the Bignoniaceae family. Commonly know as "pau d'arco" in Brazil, its inner bark is used as analgesic, anti-inflammatory, antineoplasic and diuretic at the Brazilian northeast. A validation of the plant usage has not been previously performed.

Results: Antinociceptive and antiedematogenic effects of Tabebuia avellanedae Lor. ex Griseb. inner bark were measured by nociceptive experimental models in mice. A rat paw edema test induced by carrageenan (1%) was also performed in rats to access the plant's antiedematogenic effect. The inner bark aqueous extract, administered via oral in three different concentration, namely 100, 200 and 400 mg/Kg, reduced the nociception produced by acetic acid (0.6% in water, i.p.) by 49.9%, 63.7% and 43.8%, respectively. The aqueous extract (200 and 400 mg/Kg, p.o.) reduced formalin (1%) effects only at the second phase of the experiment by 49.3% and 53.7%, respectively. Naloxone (5 mg/Kg, i.p.) was not able to revert the extract effect, however caffeine (10 mg/Kg, i.p.) reverted its effect by 19.8% at the second phase of the formalin test. The aqueous extract (200 mg/Kg, p.o.) inhibited edema by 12.9% when we used the rat paw edema model. The acute toxicity was low in mice.

Conclusion: The T. avellanedae inner bark aqueous extract presented antinociceptive and antiedematogenic activities at the used models, with a possible antinociceptive effect associated to the adenosine system.

References

    1. Ueda S, Umemura T, Dohguchi K, Matsuzaki T, Tokuda H, Nishino H, Iwashima A. Production of anti-tumour-promoting furanonaphthoquinones in Tabebuia avellanedae cell cultures. Phytochemistry. 1994;36:323–325. doi: 10.1016/S0031-9422(00)97069-9.
    1. de Santana CF, de Lima O, d'Albuquerque IL, Lacerda AL, Martins DG. Antitumoral and toxicological properties of extracts of bark and various wood components of Pau d'arco (Tabebuia avellanedae). Rev Inst Antibiot (Recife) 1968;8:89–94.
    1. Almeida ER. Plantas medicinais brasileiras: Conhecimentos populares e científicos: HEMUS. 1834.
    1. Falkenberg MB. Quinonas. Farmacognosia - da planta ao medicamento Edited by UFRGS/UFSC. pp. 821. Porto Alegre: Editora da UFRGS; 1999. p. 821.
    1. Panizza S. Plantas que curam: cheiro de mato São Paulo: IBRASA. 1997.
    1. Steinert J, Khalaf H, Rimpler M. HPLC separation and determination of naphto-[2,3,6]-furan-4,9-diones and related compounds in extracts of Tabebuia avellanedae (Bignoniaceae). J Chromatogr A. 1995;693:281–287. doi: 10.1016/0021-9673(94)01128-2.
    1. Portillo A, Vila R, Freixa B, Adzet T, Canigueral S. Antifungal activity of Paraguayan plants used in traditional medicine. J Ethnopharmacol. 2001;76:93–98. doi: 10.1016/S0378-8741(01)00214-8.
    1. de Almeida ER, da Silva Filho AA, dos Santos ER, Lopes CA. Antiinflammatory action of lapachol. J Ethnopharmacol. 1990;29:239–241. doi: 10.1016/0378-8741(90)90061-W.
    1. Steinert J, Khalaf H, Rimpler M. High-performance liquid chromatographic separation of some naturally occurring naphthoquinones and anthraquinones. J Chromatogr A. 1996;723:206–209. doi: 10.1016/0021-9673(95)00841-1.
    1. Winter CA, Risley EA, Nuss GW. Carrageenan-induced edema in hind paw of the rat as a assay for antiinflammatory drugs. Proc Soc Exp Biol Med. 1962;111:547–547.
    1. Collier HO, Dinneen LC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol. 1968;32:295–310.
    1. Wei ET, Kiang JG, Buchan P, Smith TW. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw. J Pharmacol Exp Ther. 1986;238:783–787.
    1. Takahashi RN, Paz MM. Influence of naloxone on analgesic effects of antidepressants in mice. Braz J Med Biol Res. 1987;20:607–610.
    1. Yeh SY. Potentiation of pentazocine antinociception by tripelennamine in the rat. J Pharmacol Exp Ther. 1985;235:683–689.
    1. Di Rosa M, Giround JP, Willoughby PA. Studies on the mediators of acute inflammatory response induced in rat in different sites by carrageenan and tupentine. J Pathol Bacteriol. 1971;104:5–29.
    1. Fredholm BB, Gustafsson LE, Hedquist P, Sollevi A. Adenosine in the regulation of neurotransmitter release in the peripheral nervous system. Regulation functions of adenosine Edited by Berne RM, Rall TW, Rubio R. pp. 479–493. Boston: Martinus Nijhoff; 1983. pp. 479–493.
    1. Sawynok J. Purine and nociception. Purinergics approaches in experimental therapeutics Edited by Jacobson K, Jarvis MF. pp. 495–513. New York: Wiley & Sons; 1997. pp. 495–513.
    1. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992;51:5–17. doi: 10.1016/0304-3959(92)90003-T.
    1. Husnkaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflamamatory pain. Pain. 1987;30:103–119.
    1. Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol. 1993;54:275–287.
    1. Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev. 1993;45:43–85.
    1. Daval JL, Nehlig A, Nicolas F. Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci. 1991;49:1435–1453. doi: 10.1016/0024-3205(91)90043-B.
    1. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977;4:161–174. doi: 10.1016/0304-3959(77)90130-0.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit